Organogenesis Holdings Inc expected to post a loss of 1 cent a share - Earnings Preview

Organogenesis Holdings

25/02/2025 21:47

Organogenesis Holdings Inc ORGO.OQ ORGO.O is expected to show a rise in quarterly revenue when it reports  results on February 27 for the period ending December 31 2024

The Canton Massachusetts-based  company is expected to report a 10.0% increase in revenue to $109.6 million from $99.65 million a year ago, according to the mean estimate from 3 analysts, based on LSEG data.

​LSEG's mean analyst estimate for Organogenesis Holdings Inc is for a loss of 1 cent per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Organogenesis Holdings Inc is $5.00​, above​ its last closing price of $3.18. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Sep. 30 2024
-0.02
-0.01
0.09
Beat
700
Jun. 30 2024
0.00
0.00
0.04
Beat
Mar. 31 2024
-0.03
-0.03
-0.02
Beat
25​
Dec. 31 2023
0.01
0.01
0.00
Missed
-100
​​Sep. 30 2023
0.00
0.01
0.02
Beat
300
Jun. 30 2023
0.02
0.03
0.04
Beat
60​
Mar. 31 2023
-0.02
-0.02
-0.02
Met
0
Dec. 31 2022
0.05
0.05
0.06
Beat
20

This summary was machine generated February 25 at 21:47 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)